共 50 条
- [21] Efficacy and safety of Anluohuaxian in the treatment of patients with severe Coronavirus disease 2019- a multicenter, open label, randomized controlled study: a structured summary of a study protocol for a randomised controlled trialTrials, 21Chi ZhangJiawen LiZhao WuHe WangChengli QueHong ZhaoGuiqiang Wang
- [22] Prognostic and Predictive Biomarkers in Patients With Coronavirus Disease 2019 Treated With Tocilizumab in a Randomized Controlled Trial*CRITICAL CARE MEDICINE, 2022, 50 (03) : 398 - 409Tom, JenniferBao, MinTsai, LarryQamra, AditiSummers, DavidCarrasco-Triguero, MontserratMcBride, JacquelineRosenberger, Carrie M.Lin, Celia J. F.Stubbings, WilliamBlyth, Kevin G.Carratala, JordiFrancois, BrunoBenfield, ThomasHaslem, DerrickBonfanti, Paolovan Der Leest, Cor H.Rohatgi, NidhiWiese, LotharLuyt, Charles EdouardKheradmand, FarrahRosas, Ivan O.Cai, Fang
- [23] A Prospective, Randomized, Open-Label Trial of Early versus Late Favipiravir Therapy in Hospitalized Patients with COVID-19ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2020, 64 (12)Doi, YoheiHibino, MasayaHase, RyotaYamamoto, MichikoKasamatsu, YuHirose, MasahiroMutoh, YoshikazuHomma, YoshitoTerada, MasakiOgawa, TakuKashizaki, FumihiroYokoyama, ToshihikoKoba, HayatoKasahara, HidekiYokota, KazuhisaKato, HideakiYoshida, JunichiKita, ToshiyukiKato, YasuyukiKamio, TadashiKodama, NobuhiroUchida, YujiroIkeda, NobuhiroShinoda, MasahiroNakagawa, AtsushiNakatsumi, HirokiHoriguchi, TomoyaIwata, MitsunagaMatsuyama, AkifumiBanno, SumiKoseki, TakenaoTeramachi, MayumiMiyata, MasamiTajima, ShigeruMaeki, TakahiroNakayama, EriTaniguchi, SatoshiLim, Chang KwengSaijo, MasayukiImai, TakumiYoshida, HisakoKabata, DaijiroShintani, AyumiYuzawa, YukioKondo, Masashi
- [24] Anakinra in hospitalized non-intubated patients with coronavirus disease 2019: a Systematic review and meta-analysisRHEUMATOLOGY, 2021, 60 (12) : 5527 - 5537Barkas, FotiosFilippas-Ntekouan, SebastianKosmidou, MariaLiberopoulos, EvangelosLiontos, AngelosMilionis, Haralampos
- [25] Therapeutic versus Prophylactic Bemiparin in Hospitalized Patients with Nonsevere COVID-19 Pneumonia (BEMICOP Study): An Open-Label, Multicenter, Randomized, Controlled TrialTHROMBOSIS AND HAEMOSTASIS, 2022, 122 (02) : 295 - 299Marcos-Jubilar, MariaCarmona-Torre, FranciscoVidal, RosaRuiz-Artacho, PedroFilella, DavidCarbonell, CristinaJimenez-Yuste, VictorSchwartz, JuanaLlamas, PilarAlegre, FelixSadaba, BelenNunez-Cordoba, JorgeYuste, Jose R.Fernandez-Garcia, JavierLecumberri, Ramon
- [26] Efficacy and safety of the investigational complement C5 inhibitor zilucoplan in patients hospitalized with COVID-19: an open-label randomized controlled trialRESPIRATORY RESEARCH, 2022, 23 (01)De Leeuw, ElisabethVan Damme, Karel F. A.Declercq, JozefienBosteels, CedricMaes, BastiaanTavernier, Simon J.Detalle, LaurentSmart, TrevorGlatt, SophieDebeuf, NincyDeckers, JulieLameire, SahineVandecasteele, Stefaan J.De Neve, NikolaasDemedts, Ingel K.Govaerts, ElkeKnoop, ChristianeVanhove, KarolienMoutschen, MichelTerryn, WimDepuydt, PieterVan Braeckel, EvaHaerynck, FilomeenHendrickx, Tine C. J.Parrein, VanessaLalla, MariannaBrittain, ClaireLambrecht, Bart N.
- [27] Efficacy and safety of the investigational complement C5 inhibitor zilucoplan in patients hospitalized with COVID-19: an open-label randomized controlled trialRespiratory Research, 23Elisabeth De LeeuwKarel F. A. Van DammeJozefien DeclercqCedric BosteelsBastiaan MaesSimon J. TavernierLaurent DetalleTrevor SmartSophie GlattNincy DebeufJulie DeckersSahine LameireStefaan J. VandecasteeleNikolaas De NeveIngel K. DemedtsElke GovaertsChristiane KnoopKarolien VanhoveMichel MoutschenWim TerrynPieter DepuydtEva Van BraeckelFilomeen HaerynckTine C. J. HendrickxVanessa ParreinMarianna LallaClaire BrittainBart N. Lambrecht
- [28] Effect of Tenofovir Alafenamide Fumarate on the outcomes of hospitalized COVID-19 patients: a prospective, block-balanced, open-label, randomized controlled trialBMC PHARMACOLOGY & TOXICOLOGY, 2024, 25 (01)Pouri, Nazanin YazdanEshkiki, Zahra ShokatiTalebi, AfshinCheraghian, BahmanAhmadi, FatemehNeisi, NiloofarShayesteh, Ali Akbar
- [29] Results of Open-Label non-Randomized Comparative Clinical Trial: "BromhexIne and Spironolactone for CoronavirUs Infection requiring hospiTalization (BISCUIT)KARDIOLOGIYA, 2020, 60 (11) : 4 - 15Mareev, V. YuOrlova, Ya A.Plisyk, A. G.Pavlikova, E. P.Matskeplishvili, S. T.Akopyan, Z. A.Seredenina, E. M.Potapenko, A., VAgapov, M. A.Asratyan, D. A.Dyachuk, L., ISamokhodskaya, L. M.Mershina, E. A.Sinitsyn, V. E.Pakhomov, P., VBulanova, M. M.Fuks, A. A.Mareev, Yu, VBegrambekova, Yu L.Kamalov, A. A.
- [30] Combination of Hua Shi Bai Du granule (Q-14) and standard care in the treatment of patients with coronavirus disease 2019 (COVID-19): A single-center, open-label, randomized controlled trialPHYTOMEDICINE, 2021, 91Liu, JiaYang, WeiLiu, YueLu, ChengRuan, LianguoZhao, ChenHuo, RuiliShen, XinMiao, QingLv, WenliangLi, HaoShi, HuaxinHu, LijieYang, ZhixuZhang, LiWang, BingDong, GuojuXian, YongyueLi, BinZhou, ZhenqiXu, ChunyanChen, YingyingBian, YongjunGuo, JingYang, JinliangWang, JianQi, WenshengChen, SupingChen, YangYan, BeiWang, WeiLi, JingXie, XiaoleiXu, MingJiang, JianxinWang, GangCong, XiaodongZhu, HaoningShi, JiahengLeng, LuxingLi, DongxuGuo, LanpingHuang, Luqi